Pure Global AI
MCA MCA-T-501

MCA-T-501/04, version 2 – 24 January 2025

Sponsor Indemnification for Sites and Investigators
GambiaMedicines Control Agency, The GambiaClinical TrialsCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

MCA-T-501/04, version 2 – 24 January 2025 is the official MCA identifier for “Sponsor Indemnification for Sites and Investigators”. MCA-T-501/04, version 2 – 24 January 2025 is the official identifier MCA uses for this instrument.

Instrument
MCA-T-501
Full name
MCA-T-501/04, version 2 – 24 January 2025
Category
Clinical Trials
Source links
Source publication
English
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Sponsor Indemnification for Sites and Investigators

Complete one-page sponsor indemnification template for sites and investigators, version 2 dated 24 January 2025, retained as necessary common clinical-trial context. The document expressly labels its text as suggested wording and guidance rather than an exclusive approach. Its compound and indemnity wording is preserved without turning the template into a universal device approval requirement. Later revisions and current applicability remain unverified.

MCA-T-501/04, version 2 – 24 January 2025 is the official identifier MCA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.